ZA834119B - Optically active derivatives of n-arylated oxazolidine-2-one,the process for preparing same and their application in therapeutics - Google Patents

Optically active derivatives of n-arylated oxazolidine-2-one,the process for preparing same and their application in therapeutics

Info

Publication number
ZA834119B
ZA834119B ZA834119A ZA834119A ZA834119B ZA 834119 B ZA834119 B ZA 834119B ZA 834119 A ZA834119 A ZA 834119A ZA 834119 A ZA834119 A ZA 834119A ZA 834119 B ZA834119 B ZA 834119B
Authority
ZA
South Africa
Prior art keywords
arylated
oxazolidine
therapeutics
application
optically active
Prior art date
Application number
ZA834119A
Other languages
English (en)
Inventor
Margherita Strolin-Benedetti
Patrick Guerret
Michel Langlois
Philippe Dostert
Original Assignee
Delalande Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Delalande Sa filed Critical Delalande Sa
Publication of ZA834119B publication Critical patent/ZA834119B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/18—Oxygen atoms
    • C07D263/20—Oxygen atoms attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/18—Oxygen atoms
    • C07D263/20—Oxygen atoms attached in position 2
    • C07D263/24—Oxygen atoms attached in position 2 with hydrocarbon radicals, substituted by oxygen atoms, attached to other ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/14—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D317/28—Radicals substituted by nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ZA834119A 1982-06-08 1983-06-07 Optically active derivatives of n-arylated oxazolidine-2-one,the process for preparing same and their application in therapeutics ZA834119B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8209972A FR2528046B1 (fr) 1982-06-08 1982-06-08 Derives de l'oxazolidinone-2 n-arylee optiquement actifs, inhibiteurs specifiques et reversibles de la monoamine oxydase de type b et leur procede de preparation

Publications (1)

Publication Number Publication Date
ZA834119B true ZA834119B (en) 1984-03-28

Family

ID=9274766

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA834119A ZA834119B (en) 1982-06-08 1983-06-07 Optically active derivatives of n-arylated oxazolidine-2-one,the process for preparing same and their application in therapeutics

Country Status (13)

Country Link
US (1) US4598084A (sv)
JP (1) JPS5980668A (sv)
AU (1) AU1546283A (sv)
BE (1) BE896972A (sv)
CH (3) CH657362A5 (sv)
DE (1) DE3320394A1 (sv)
FR (1) FR2528046B1 (sv)
GB (3) GB2121413B (sv)
IT (1) IT1164269B (sv)
LU (1) LU84851A1 (sv)
NL (1) NL8302013A (sv)
SE (2) SE8303136L (sv)
ZA (1) ZA834119B (sv)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60241893A (ja) * 1984-05-15 1985-11-30 Kanegafuchi Chem Ind Co Ltd 光学活性（ｓ）―オキサゾリジノン誘導体の製造方法
DE3525648A1 (de) * 1985-07-18 1987-01-29 Bokel Heinz Hermann Dr 1-oxa-2-oxo-2-r-3-aza-5-z-cyclopentanderivate
FR2609029B1 (fr) * 1986-12-30 1989-12-08 Delalande Sa Derives 5-aminoethyles de l'oxazolidinone-2, leur procede de preparation et leur application en therapeutique
AU7778087A (en) * 1986-09-03 1988-04-14 Delalande S.A. 5-aminoethyloxazolidin-2-one derivatives
FR2603279B1 (fr) * 1986-09-03 1988-12-16 Rech Ind Benzyloxy-phenyl-oxazolidinones, procede de preparation et utilisation en therapeutique
FR2626877B1 (fr) * 1988-02-05 1991-04-05 Delalande Sa Ethers alkyliques ou benzyliques du phenol, leurs procedes de preparation et leur application en therapeutique
US5196543A (en) * 1989-10-17 1993-03-23 Delalande S.A. 3-aryloxazolidinone derivatives, process for their preparation and their use in therapy
US5235063A (en) * 1989-10-17 1993-08-10 Delalande S.A. Process of preparing by condensation certain
JPH06508836A (ja) * 1991-06-26 1994-10-06 セプラコア，インコーポレーテッド 光学的に純粋なｒ（＋）オンダンセトロンを使用する嘔吐、吐き気および他の障害の治療のための方法および組成物
AU3147593A (en) * 1991-11-26 1993-06-28 Sepracor, Inc. Methods and compositions for treating hypertension, angina and other disorders using optically pure (-) amlodipine
CA2371822A1 (en) 1999-03-01 2000-09-08 Sepracor Inc. Methods for treating apnea and apnea disorders using optically pure r(+)ondansetron

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2356422A1 (fr) * 1976-03-01 1978-01-27 Delalande Sa Nouveaux hydroxymethyl-5 oxazolidinone-2, leur procede de preparation et leur application en therapeutique
FR2380780A2 (fr) * 1977-02-22 1978-09-15 Delalande Sa Application en therapeutique des hydroxymethyl-5 oxazolidinones-2, notamment comme antidepresseurs
LU80081A1 (fr) * 1977-08-26 1979-05-15 Delalande Sa Nouvelles hydroxymethyl-5 oxazolidinones-2,leur procede de preparation et leur application therapeutique
FR2428032A1 (fr) * 1978-06-09 1980-01-04 Delalande Sa Nouvelles oxazolidimones, oxazolidinethiones et pyrrolidinones, leur procede de preparation et leur application en therapeutique
US4348393A (en) * 1978-06-09 1982-09-07 Delalande S.A. N-Aryl oxazolidinones, oxazolidinethiones, pyrrolidinones, pyrrolidines and thiazolidinones

Also Published As

Publication number Publication date
BE896972A (fr) 1983-12-06
US4598084A (en) 1986-07-01
GB2157693A (en) 1985-10-30
GB8512020D0 (en) 1985-06-19
FR2528046A1 (fr) 1983-12-09
GB8315433D0 (en) 1983-07-13
SE8802281D0 (sv) 1988-06-17
CH661500A5 (fr) 1987-07-31
NL8302013A (nl) 1984-01-02
GB8512019D0 (en) 1985-06-19
GB2157692A (en) 1985-10-30
GB2121413A (en) 1983-12-21
IT1164269B (it) 1987-04-08
LU84851A1 (fr) 1985-03-29
SE8303136L (sv) 1983-12-09
CH661507A5 (fr) 1987-07-31
JPS5980668A (ja) 1984-05-10
IT8321497A0 (it) 1983-06-07
GB2157693B (en) 1986-05-08
GB2121413B (en) 1986-05-08
SE8802281L (sv) 1988-06-17
FR2528046B1 (fr) 1985-06-21
AU1546283A (en) 1983-12-15
GB2157692B (en) 1986-05-08
SE8303136D0 (sv) 1983-06-03
DE3320394A1 (de) 1983-12-08
CH657362A5 (fr) 1986-08-29

Similar Documents

Publication Publication Date Title
ZA817675B (en) New nor-tropane and granatane derivatives,the process for preparing the same and their application in therapeutics
AU526714B2 (en) Novel 5-hydroxymethyl oxazolidinones, the method of preparing them and their application in therapeutics
ZA834704B (en) New 3-amino quinuclidine derivatives,the process for preparing same and the application thereof in therapeutics
GB2085444B (en) Novel anticoagulant agmatine derivatives and process for the preparation thereof
PT72279B (en) Process for the preparation of 2-azidomethyl-5-phenyl-1h-2,3-dihydro-1,4-benzodiazepines and salts thereof
ZA813567B (en) Novel n-aryl azolone derivatives,the process for preparing the same and their application in therapeutics
EG15890A (en) Pyridoxine derivatives,process for preparing them and use in therapeutics
ZA801680B (en) 2-imidazoline derivatives,process for the preparation thereof and the pharmaceutical composition of the same
DE3071484D1 (en) Linear polychlorophosphazenes, process for their preparation and their use
DE2961338D1 (en) Antibiotics, process for their preparation, and their use as plant protecting agents
DE3064165D1 (en) (e)-5-(2-halogenovinyl)-arabinofuranosyluracil, process for preparation thereof, and uses thereof
ZA834119B (en) Optically active derivatives of n-arylated oxazolidine-2-one,the process for preparing same and their application in therapeutics
GB2053196B (en) Derivatives of 5h-furanone-2 and of 3h-dihydrofuranone-2,the process for preparing the same and their application in therapeutics
DE3060345D1 (en) Fluortriazine derivatives, process for the preparation of fluortriazin-derivatives and reactive dyes and their application
YU215484A (en) Process for preparing glyoxale, alkylglyoxales and their acethales
EP0113123A3 (en) Mannoglucan derivatives and process for preparing the same
ZA832657B (en) Oxazole derivatives,production and use thereof
DE3463041D1 (en) Tributylphenolether-glycidyl-sulphonates, process for their preparation and their use
ZA802673B (en) Novel derivatives of 5h-furanone-2 and of 3h-dihydrofuranone-2, the process for preparing the same and their application in therapeutics
DE3470033D1 (en) Derivatives of dimethyl-3-nitro-4-amino-aniline, process for their preparation and their use in the dyeing of keratin fibres
ZA792799B (en) Novel n-aryl oxazolidinones,oxazolidinethiones,pyrrolidinones,pyrrolidinines and thiazolidinones,process for their preparation and their application in therapeutics
DE3168442D1 (en) Tetrazolylcoumarin derivatives, process for preparing the same and composition containing the same
ZA80160B (en) Novel nor-tropane derivatives,a process for preparing same and their application in therapeutics
DE3364376D1 (en) Isoindolazines, process for their preparation and their use
DE3062050D1 (en) Gelatins, process for their preparation and their use